Since the pandemic in 2019, coronavirus 2019 (COVID-19) has continued to be linked with
a variety of organ systems and complications. While it is generally considered a respiratory …

Cardiac complications in patients with COVID-19 have been described in the literature with
an important impact on outcome. The primary objective of our systematic review was to …

Objective Myocardial damage occurs in up to 25% of coronavirus disease 2019 (COVID‐19)
cases. While veno‐venous extracorporeal life support (V‐V ECLS) is used as respiratory …

A 3-year-old girl presenting with fever, mucocutaneous inflammation, and acute
gastrointestinal symptoms met criteria for the multisystem inflammatory syndrome in children …

Despite remarkable improvements in the past two decades, the annual cardiovascular
mortality rate has remained higher for women than for men. Pregnant women represent an …

Background We previously described percutaneous thrombectomy and right ventricular (RV)
mechanical support of a coronavirus disease 2019 (COVID-19) patient with a massive …

Introduction The hypercoagulability state induced by COVID-19 has been well established
and various forms of subsequent thromboembolic events have been reported throughout …

Background: Coronavirus disease 2019 (COVID-19) can present with significant cardiac
dysfunction, including cardiogenic shock. Mechanical circulatory support with an Impella …

Abstract Background Coronavirus disease 2019 (COVID-19) is a manifestation of severe
acute respiratory syndrome coronavirus 2, which results in many different complications …

Inflammation and thrombogenic effects of coronavirus disease 2019 (COVID‐19) can lead to
cardiovascular complications in patients even after recovery from COVID‐19. Intracardiac …